Buprenorphine Treatment: Advanced Practice Nurses Add Capacity.
Health Aff (Millwood)
; 41(9): 1231-1237, 2022 09.
Article
en En
| MEDLINE
| ID: mdl-36067440
During the COVID-19 pandemic, there was slower growth in the number of new waivers authorizing clinicians to provide buprenorphine treatment for opioid use disorder. However, treatment capacity grew at a stable rate as a result of already authorized clinicians obtaining waivers for larger patient panels. Advanced practice nurses accounted for the largest portion of capacity growth during the pandemic.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Buprenorfina
/
Tratamiento Farmacológico de COVID-19
/
Trastornos Relacionados con Opioides
Límite:
Humans
Idioma:
En
Revista:
Health Aff (Millwood)
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Estados Unidos